Disclosures:  Pharmaceutical companies commonly request advice from physicians in academia on designs of clinical trials for patients with metastatic colorectal cancer.  By providing this advice, we are able to ensure that the clinical trials best meet the needs of the patients and are designed to give the novel therapy the best chance to work.  We are compensated in some cases for our time.  In separate situations, we may give a lecture to other physicians on the best way to use chemotherapy based on our research and clinical experience and be compensated for our time.  In addition, research funding may be provided by a pharmaceutical company to researchers in academia to evaluate a new drug in the laboratory.  In any acedmic center, these relationships are reviewed by internal committees designed to indentify and rectify any conflicts of interest that may be present.
The following are the disclosures for the last 5 years for the website creator:  Bristol-Myers Squibb, Sanofi-aventis, Astra-Zeneca, Genentech/Roche, Pfizer, Circadian, GSK

This website is neither supported by nor affiliated with any pharmaceutical company.  The opinions are solely those of the author.